These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
543 related items for PubMed ID: 11729476
1. [Neoadjuvant chemotherapy for invasive bladder cancer]. Kageyama Y, Kihara K. Gan To Kagaku Ryoho; 2001 Nov; 28(12):1838-44. PubMed ID: 11729476 [Abstract] [Full Text] [Related]
2. [Neoadjuvant and adjuvant chemotherapy of bladder cancer]. Kuroda M, Kotake T. Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():362-9. PubMed ID: 7986116 [Abstract] [Full Text] [Related]
3. [Neoadjuvant chemotherapy in muscle-invasive bladder cancer]. Miyanaga N, Akaza H. Gan To Kagaku Ryoho; 2007 Nov; 34(11):1745-9. PubMed ID: 18030008 [Abstract] [Full Text] [Related]
4. Neoadjuvant chemotherapy is not (yet) standard treatment for muscle-invasive bladder cancer. Sternberg CN, Parmar MK. J Clin Oncol; 2001 Sep 15; 19(18 Suppl):21S-26S. PubMed ID: 11560967 [No Abstract] [Full Text] [Related]
7. Primary cisplatin, methotrexate and vinblastine aiming at bladder preservation in invasive bladder cancer: multivariate analysis on prognostic factors. Angulo JC, Sanchez-Chapado M, Lopez JI, Flores N. J Urol; 1996 Jun 15; 155(6):1897-902. PubMed ID: 8618282 [Abstract] [Full Text] [Related]
8. Plenary debate of randomized phase III trial of neoadjuvant MVAC plus cystectomy versus cystectomy alone in patients with locally advanced bladder cancer. Bajorin DF. J Clin Oncol; 2001 Sep 15; 19(18 Suppl):17S-20S. PubMed ID: 11560966 [No Abstract] [Full Text] [Related]
9. The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer. Ennis RD, Petrylak DP, Singh P, Bagiella E, O'Toole KM, Benson MC, Olsson CA. J Urol; 2000 May 15; 163(5):1413-8. PubMed ID: 10751847 [Abstract] [Full Text] [Related]
10. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience. Stöckle M, Meyenburg W, Wellek S, Voges GE, Rossmann M, Gertenbach U, Thüroff JW, Huber C, Hohenfellner R. J Urol; 1995 Jan 15; 153(1):47-52. PubMed ID: 7966789 [Abstract] [Full Text] [Related]
11. Study of the prediction system for clinical response to M-VAC neoadjuvant chemotherapy for bladder cancer. Takata R, Obara W, Fujioka T. Aktuelle Urol; 2010 Jan 15; 41 Suppl 1():S41-5. PubMed ID: 20094952 [Abstract] [Full Text] [Related]
12. [Current status of adjuvant chemotherapy of invasive bladder cancer]. Ozono S, Sasaki K, Watanabe S, Maruyama Y, Ohara S, Babaya K, Yamada K, Hirao Y, Okajima E. Hinyokika Kiyo; 1991 Dec 15; 37(12):1589-95. PubMed ID: 1785379 [Abstract] [Full Text] [Related]
19. The current status of perioperative chemotherapy for invasive bladder cancer: a multiinstitutional retrospective study in Japan. Matsui Y, Nishiyama H, Watanabe J, Teramukai S, Ono Y, Ohshima S, Fujimoto K, Hirao Y, Fukushima M, Ogawa O. Int J Clin Oncol; 2005 Apr 15; 10(2):133-8. PubMed ID: 15864700 [Abstract] [Full Text] [Related]
20. Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer. Milowsky MI, Stadler WM, Bajorin DF. BJU Int; 2008 Nov 15; 102(9 Pt B):1339-44. PubMed ID: 19035902 [Abstract] [Full Text] [Related] Page: [Next] [New Search]